-
Evercore ISI Group Maintains Outperform Rating for TORM: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 276Read More...Evercore ISI Group has decided to maintain its Outperform rating of TORM (NASDAQ:TRMD) and raise its price target from $42.00 to $44.00. Shares of TORM are trading down 0.9% over the last 24 hours, at $32.90 per share. A move to $44.00 would account for a 33.74% increase from the current share...
-
Jefferies Maintains Buy Rating for Visa: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 258Read More...Jefferies has decided to maintain its Buy rating of Visa (NYSE:V) and raise its price target from $305.00 to $320.00. Shares of Visa are trading up 0.51% over the last 24 hours, at $279.69 per share. A move to $320.00 would account for a 14.41% increase from the current share price. About Visa Visa...
-
Truist Securities Maintains Hold Rating for ABM Indus: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 305Read More...Truist Securities has decided to maintain its Hold rating of ABM Indus (NYSE:ABM) and lower its price target from $53.00 to $45.00. Shares of ABM Indus are trading up 0.0% over the last 24 hours, at $43.35 per share. A move to $45.00 would account for a 3.81% increase from the current share price....
-
Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 274Read More...Chardan Capital has decided to maintain its Buy rating of Dyne Therapeutics (NASDAQ:DYN) and raise its price target from $20.00 to $31.00. Shares of Dyne Therapeutics are trading up 1.02% over the last 24 hours, at $26.71 per share. A move to $31.00 would account for a 16.06% increase from the...
-
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 276Read More...Morgan Stanley has decided to maintain its Equal-Weight rating of Revolution Medicines (NASDAQ:RVMD) and lower its price target from $84.00 to $71.00. Shares of Revolution Medicines are trading up 2.06% over the last 24 hours, at $32.18 per share. A move to $71.00 would account for a 120.63%...
-
RBC Capital Maintains Sector Perform Rating for Dana: Here's What You Need To Know
Friday, March 8, 2024 - 1:00pm | 322Read More...RBC Capital has decided to maintain its Sector Perform rating of Dana (NYSE:DAN) and lower its price target from $19.00 to $15.00. Shares of Dana are trading up 0.0% over the last 24 hours, at $12.51 per share. A move to $15.00 would account for a 19.9% increase from the current share price. About...
-
Susquehanna Maintains Positive Rating for Viavi Solutions: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 297Read More...Susquehanna has decided to maintain its Positive rating of Viavi Solutions (NASDAQ:VIAV) and raise its price target from $12.00 to $14.00. Shares of Viavi Solutions are trading down 0.15% over the last 24 hours, at $10.97 per share. A move to $14.00 would account for a 27.58% increase from the...
-
Piper Sandler Maintains Overweight Rating for Permian Resources: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 286Read More...Piper Sandler has decided to maintain its Overweight rating of Permian Resources (NYSE:PR) and raise its price target from $17.00 to $22.00. Shares of Permian Resources are trading up 1.09% over the last 24 hours, at $15.80 per share. A move to $22.00 would account for a 39.24% increase from the...
-
Citigroup Maintains Buy Rating for CrowdStrike Holdings: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 281Read More...Citigroup has decided to maintain its Buy rating of CrowdStrike Holdings (NASDAQ:CRWD) and raise its price target from $320.00 to $425.00. Shares of CrowdStrike Holdings are trading up 0.13% over the last 24 hours, at $330.00 per share. A move to $425.00 would account for a 28.79% increase from the...
-
Craig-Hallum Maintains Hold Rating for Innovative Ind Props: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 293Read More...Craig-Hallum has decided to maintain its Hold rating of Innovative Ind Props (NYSE:IIPR) and raise its price target from $80.00 to $100.00. Shares of Innovative Ind Props are trading down 0.22% over the last 24 hours, at $96.50 per share. A move to $100.00 would account for a 3.63% increase from...
-
Barclays Maintains Equal-Weight Rating for ODDITY Tech: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 283Read More...Barclays has decided to maintain its Equal-Weight rating of ODDITY Tech (NASDAQ:ODD) and raise its price target from $42.00 to $46.00. Shares of ODDITY Tech are trading up 2.15% over the last 24 hours, at $44.75 per share. A move to $46.00 would account for a 2.79% increase from the current share...
-
Truist Securities Maintains Buy Rating for Iovance Biotherapeutics: Here's What You Need To Know
Thursday, March 7, 2024 - 1:00pm | 305Read More...Truist Securities has decided to maintain its Buy rating of Iovance Biotherapeutics (NASDAQ:IOVA) and raise its price target from $17.00 to $26.00. Shares of Iovance Biotherapeutics are trading up 1.92% over the last 24 hours, at $17.49 per share. A move to $26.00 would account for a 48.66%...
-
JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know
Wednesday, March 6, 2024 - 1:00pm | 267Read More...JP Morgan has decided to maintain its Overweight rating of Privia Health Gr (NASDAQ:PRVA) and lower its price target from $38.00 to $30.00. Shares of Privia Health Gr are trading up 0.0% over the last 24 hours, at $21.08 per share. A move to $30.00 would account for a 42.31% increase from the...
-
Stifel Maintains Hold Rating for MeridianLink: Here's What You Need To Know
Wednesday, March 6, 2024 - 1:00pm | 250Read More...Stifel has decided to maintain its Hold rating of MeridianLink (NYSE:MLNK) and lower its price target from $20.00 to $18.00. Shares of MeridianLink are trading up 1.11% over the last 24 hours, at $19.10 per share. A move to $18.00 would account for a 5.76% decrease from the current share price....
-
Alliance Global Partners Maintains Buy Rating for Ooma: Here's What You Need To Know
Wednesday, March 6, 2024 - 1:00pm | 301Read More...Alliance Global Partners has decided to maintain its Buy rating of Ooma (NYSE:OOMA) and lower its price target from $16.00 to $14.50. Shares of Ooma are trading up 1.11% over the last 24 hours, at $10.00 per share. A move to $14.50 would account for a 45.0% increase from the current share price....






